Jay (Jeonghun) Jang, MBA

VP of Business Development at Medipixel

Jay (Jeonghun) Jang, MBA has extensive work experience in the medical device industry. Jay (Jeonghun) began their career in 2005 as Sales and Marketing Manager at Ergomax venture company. In 2006, they moved to The Janssen Pharmaceutical Companies of Johnson & Johnson as a Sales Representative. In 2010, they returned to Boston Scientific as a Sr. Coronary Sales Representative. In 2014, they joined Abbott as a Product Manager (Endovascular) and Sr. Endovascular sales rep. In 2017, they went back to Boston Scientific as a Marketing Manager and Sr. Product Manager. Currently, they are VP of Business Development and VP of Business Strategy at Medipixel.

Jay (Jeonghun) Jang holds an MBA from the Kelley School of Business at Indiana University, an Executive MBA from SKK GSB Sungkyunkwan University, and a Bachelor's degree in Sports Medicine from Kyung Hee University. Jay (Jeonghun) also completed an Executive Education program in Data Science from UC Berkeley School of Information in 2019. In addition, Jay has obtained numerous certifications from Google, LinkedIn, and Asan Medical Center (AMC). These certifications include Attract and Engage Customers with Digital Marketing, Foundations of Digital Marketing and E-commerce, Branding Your Authentic Self, Navigating Environmental Sustainability: A Guide for Leaders, Project Management Skills for Leaders, Leadership In-Residence certificate, Being Positive at Work, 2021 Medical Device Clinical Trial Training (GCP), A Design Thinking Approach to Putting the Customer First, Leading with a Heavy Heart, Marketing: Copywriting for Social Media, One-Minute Habits for Success, Powerful Prioritization with the 80/20 Rule, Pitching Your Ideas Strategically, Financial Accounting Foundations, Financial Basics Everyone Should Know, Leading in Crisis, Making Quick Decisions, Negotiation Foundations, and Sales: Sales Games for Your Teams.

Links

Previous companies

Boston Scientific logo

Timeline

  • VP of Business Development

    August, 2022 - present

  • VP of Business Strategy

    September, 2021